Trial Profile
Pilot phase 2 study of Renzapride in patients with diabetic gastroparesis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Jan 2017
Price :
$35
*
At a glance
- Drugs Renzapride (Primary)
- Indications Diabetic gastroparesis
- Focus Therapeutic Use
- 05 Jan 2017 New trial record
- 03 Jan 2017 Results published in an Endologic media release.